These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9882214)

  • 1. Eptifibatide in acute coronary syndromes.
    Segal J
    N Engl J Med; 1999 Jan; 340(1):60; author reply 61. PubMed ID: 9882214
    [No Abstract]   [Full Text] [Related]  

  • 2. Platelet glycoprotein IIb/IIIa receptor blockade with integrilin (eptifibatide) for early postinfarction angina in a patient with coronary arterial ectasia.
    Grigorov V; Goldberg L; Mekel J
    Cardiovasc J S Afr; 2002; 13(3):125-8. PubMed ID: 12193965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuation of rebound ischemia after discontinuation of heparin therapy by glycoprotein IIb/IIIa inhibition with eptifibatide in patients with acute coronary syndromes: observations from the platelet IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial.
    Lauer MA; Houghtaling PL; Peterson JG; Granger CB; Bhatt DL; Sapp SK; Simoons ML; Harrington RA; Topol EJ; Lincoff AM;
    Circulation; 2001 Dec; 104(23):2772-7. PubMed ID: 11733393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized evaluation of the efficacy of enoxaparin versus unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes receiving the glycoprotein IIb/IIIa inhibitor eptifibatide. Long-term results of the Integrilin and Enoxaparin Randomized Assessment of Acute Coronary Syndrome Treatment (INTERACT) trial.
    Fitchett DH; Langer A; Armstrong PW; Tan M; Mendelsohn A; Goodman SG;
    Am Heart J; 2006 Feb; 151(2):373-9. PubMed ID: 16442903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eptifibatide in acute coronary syndromes.
    Levin T
    N Engl J Med; 1999 Jan; 340(1):60; author reply 61. PubMed ID: 9882213
    [No Abstract]   [Full Text] [Related]  

  • 6. Contemporary view of the acute coronary syndromes.
    Moustapha A; Anderson HV
    J Invasive Cardiol; 2003 Feb; 15(2):71-9. PubMed ID: 12556619
    [No Abstract]   [Full Text] [Related]  

  • 7. Platelet glycoprotein IIb/IIIa receptor blockade in unstable coronary disease.
    Chesebro JH; Badimon JJ
    N Engl J Med; 1998 May; 338(21):1539-41. PubMed ID: 9593795
    [No Abstract]   [Full Text] [Related]  

  • 8. Management of acute coronary syndromes.
    Schulman SP; Fessler HE
    Am J Respir Crit Care Med; 2001 Sep; 164(6):917-22. PubMed ID: 11587971
    [No Abstract]   [Full Text] [Related]  

  • 9. Anti-thrombotic therapy for elderly patients with acute coronary syndromes.
    Chen YT; Tuohy ER; Krumholz HM
    Coron Artery Dis; 2000 Jun; 11(4):323-30. PubMed ID: 10860175
    [No Abstract]   [Full Text] [Related]  

  • 10. Stroke in patients with acute coronary syndromes: incidence and outcomes in the platelet glycoprotein IIb/IIIa in unstable angina. Receptor suppression using integrilin therapy (PURSUIT) trial. The PURSUIT Investigators.
    Mahaffey KW; Harrington RA; Simoons ML; Granger CB; Graffagnino C; Alberts MJ; Laskowitz DT; Miller JM; Sloan MA; Berdan LG; MacAulay CM; Lincoff AM; Deckers J; Topol EJ; Califf RM
    Circulation; 1999 May; 99(18):2371-7. PubMed ID: 10318656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tirofiban in unstable coronary disease.
    Liron M
    N Engl J Med; 1998 Oct; 339(16):1163-5. PubMed ID: 9776651
    [No Abstract]   [Full Text] [Related]  

  • 12. Safety and preliminary efficacy of one month glycoprotein IIb/IIIa inhibition with lefradafiban in patients with acute coronary syndromes without ST-elevation; a phase II study.
    Akkerhuis KM; Neuhaus KL; Wilcox RG; Vahanian A; Boland JL; Hoffmann J; Baardman T; Nehmiz G; Roth U; Klootwijk AP; Deckers JW; Simoons ML;
    Eur Heart J; 2000 Dec; 21(24):2042-55. PubMed ID: 11102255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of glycoprotein IIb/IIIa inhibition on clinical stabilization parameters in patients with unstable angina and non-Q-wave myocardial infarction.
    Okmen E; Cakmak M; Tartan Z; Cam N
    Heart Vessels; 2003 Jul; 18(3):117-22. PubMed ID: 12955426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological treatment of acute coronary syndromes.
    Hughes K
    Prof Nurse; 2003 Jan; 18(5):296-9. PubMed ID: 12599964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and methodology of the PURSUIT trial: evaluating eptifibatide for acute ischemic coronary syndromes. Platelet Glycoprotein IIb-IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy.
    Harrington RA
    Am J Cardiol; 1997 Aug; 80(4A):34B-38B. PubMed ID: 9291244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of low-molecular-weight heparin and glycoprotein IIb/IIIa inhibitors in acute coronary syndromes.
    Fernandez JS; Sadaniantz A
    Med Health R I; 2001 Feb; 84(2):37-43. PubMed ID: 11272658
    [No Abstract]   [Full Text] [Related]  

  • 17. Appropriate antiplatelet and antithrombotic therapy in patients with acute coronary syndromes: recent updates to the ACC/AHA guidelines.
    Mehta SR;
    J Invasive Cardiol; 2002 Dec; 14 Suppl E():27E-34E; quiz 35E. PubMed ID: 12668860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unstable angina and non-ST-segment elevation myocardial infarction: perspectives on combination therapy.
    Villareal RP; Kim P; Ferguson JJ; Wilson JM
    Tex Heart Inst J; 2001; 28(4):276-87. PubMed ID: 11777152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Refining the treatment of women with unstable angina--a randomized, double-blind, comparative safety and efficacy evaluation of Integrelin versus aspirin in the management of unstable angina.
    Goldschmidt-Clermont PJ; Schulman SP; Bray PF; Chandra NC; Grigoryev D; Dise KR; Sagar M; Fox RJ; Coleman LD; Richardson C; Dorsey FC; du Mee C; Kitt MM; Ouyang P; Baughman KL; Gerstenblith G
    Clin Cardiol; 1996 Nov; 19(11):869-74. PubMed ID: 8914780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Glycoprotein IIb/IIIa antagonists].
    Hennemann A
    Med Monatsschr Pharm; 2000 Dec; 23(12):385-90. PubMed ID: 11147193
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.